| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $231.0M | +289.4% |
| R&D Expense | $107.4M | -21.4% |
| SG&A Expense | $259.4M | +43.0% |
| Operating Income | -$187.3M | +28.2% |
| Interest Expense | $14.0M | +34.3% |
| Pre-tax Income | -$200.9M | +21.1% |
| Income Tax | $5.0M | +1402.4% |
| Net Income | -$206.0M | +19.3% |
| EPS (Basic) | -$2.22 | +21.6% |
| EPS (Diluted) | -$2.22 | +21.6% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $406.7M | -39.7% |
| Short-term Investments | $27.5M | +163.4% |
| Accounts Receivable | $23.3M | +552.5% |
| Inventory | $7.6M | +190.5% |
| Current Assets | $488.1M | -30.7% |
| Total Assets | $520.0M | -28.3% |
| Current Liabilities | $250.3M | -11.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$268.6M | -172.5% |
| Capital Expenditures | $974K | -45.1% |
| Investing Cash Flow | -$18.0M | -95.7% |
| Financing Cash Flow | $25.9M | -89.1% |
| Free Cash Flow | -$269.5M | -173.1% |
| Total Liabilities |
| $993.5M |
| -7.9% |
| Stockholders' Equity | -$473.5M | -33.8% |